Healthcare · Pharmaceuticals & Biotechnology
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 2,303† | 2,189† | 2,226† | 1,939† | 2,102† |
| Net profit | 184 | 2,886 | 65 | 5 | 180† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Badree Komandur | Executive Director | June 30, 2026 |
| Venkata Seetharama Raju Pakalapati | Executive Director | June 30, 2026 |
| Ameet Pratapsinh Hariani | Independent Director | June 30, 2026 |
| Homi R Khusrokhan | Independent Director | June 30, 2026 |
| Kausalya Santhanam | Independent Director | June 30, 2026 |
| Mukta Arora | Independent Director | June 30, 2026 |
| Subir Chakraborty | Independent Director | June 30, 2026 |
| Aditya Arun Kumar | Non-Executive Director | June 30, 2026 |
| Arun Kumar Pillai | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
